Cargando…
Current Challenges and Opportunities in Treating Glioblastoma
Glioblastoma multiforme (GBM), the most common and aggressive primary brain tumor, has a high mortality rate despite extensive efforts to develop new treatments. GBM exhibits both intra- and intertumor heterogeneity, lending to resistance and eventual tumor recurrence. Large-scale genomic and proteo...
Autores principales: | Shergalis, Andrea, Bankhead, Armand, Luesakul, Urarika, Muangsin, Nongnuj, Neamati, Nouri |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society for Pharmacology and Experimental Therapeutics
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5907910/ https://www.ncbi.nlm.nih.gov/pubmed/29669750 http://dx.doi.org/10.1124/pr.117.014944 |
Ejemplares similares
-
Tautomeric-Dependent Lactam Cycloaddition with Nitrile Oxide: Facile Synthesis
of 1,2,4-Oxadiazole[4,5-a]indolone Derivatives
por: Jiang, Kun-Ming, et al.
Publicado: (2017) -
Inhibition of protein disulfide isomerase in glioblastoma causes marked downregulation of DNA repair and DNA damage response genes
por: Xu, Shili, et al.
Publicado: (2019) -
Multi-omics profiling reveals key signaling pathways in ovarian cancer controlled by STAT3
por: Lu, Tiangong, et al.
Publicado: (2019) -
Research on Shelf-Life Extension Technologies for Food Sustainability: An Assessment of Scientific Activities and Networks
por: Thavorn, Jakkrit, et al.
Publicado: (2022) -
2-[(4-Methoxybenzyl)iminomethyl]phenol
por: Phurat, Chuttree, et al.
Publicado: (2010)